KINDLER JEFFREY B 4
4 · Praxis Precision Medicines, Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Praxis (PRAX) Director Jeffrey Kindler Receives Equity Awards
What Happened
Jeffrey B. Kindler, a director of Praxis Precision Medicines (PRAX), received three equity awards on February 6, 2026: 688 restricted stock units (RSUs), 478 RSUs, and a 224-share derivative award (total = 1,390 units). All grants were reported as acquisitions (Form 4 code A) with an acquisition price of $0.00 (no cash paid). The RSUs will settle in shares of common stock when they vest; the 224-share derivative award vests in monthly installments (see details below).
Key Details
- Transaction date reported: February 6, 2026; Form 4 filing date: February 10, 2026 (Accession 0001689548-26-000017).
- Awards: 688 RSUs (F1), 478 RSUs (F2), 224 derivative/option-like units (F3) — total 1,390. Reported acquisition price: $0.00 for each award.
- Vesting highlights:
- 688 RSUs: vest in two equal annual installments on the first two anniversaries of January 8, 2026 (F1).
- 478 RSUs: vest in a single installment on the earlier of June 26, 2026 or the issuer’s 2026 annual meeting (F2).
- 224 derivative units: vest in equal monthly installments on the 26th of each month, starting Feb 26, 2026, with the final installment on the earlier of June 26, 2026 or the 2026 annual meeting (F3).
- Settlement: RSUs are cashless and may be settled only by delivery of common stock (per footnotes).
- Shares owned after the transaction: not specified in the provided filing excerpt.
- No sale or exercise occurred—these are grants/awards, not open‑market purchases or dispositions.
Context
These awards are director compensation grants and do not involve an immediate cash transaction or sale of shares. The 224-unit derivative award is not an immediate exercise/sale; it simply vests into shares over the stated months. Grants like these are common for board service and are informative about compensation but do not, by themselves, indicate the director buying or selling stock.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-06+688→ 688 total - Award
Common Stock
[F2]2026-02-06+478→ 1,166 total - Award
Stock Option (Right to Buy)
[F3]2026-02-06+224→ 224 totalExercise: $319.57Exp: 2036-02-06→ Common Stock (224 underlying)
Footnotes (3)
- [F1]Mr. Kindler was awarded 688 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in two equal annual installments occurring on the first two anniversaries of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Mr. Kindler was awarded 478 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F3]The shares subject to this option shall vest in equal monthly installments occurring on the 26th day of each month, with the first such installment occurring on February 26, 2026 and the final such installment occurring on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders.